GERN
USDGeron Corporation Common Stock
$1.150-0.050 (-4.167%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.200
High
$1.220
Low
$1.140
Volume
8.19M
Company Fundamentals
Market Cap
733.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
7.83M
Exchange
NMS
Currency
USD
52-Week Range
Low $1.09Current $1.150High $4.5
Related News
BusinessWire
Geron Corporation to Present at Upcoming Investor Conferences
Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Harout Semerjian, Chief Executive Officer, is scheduled
View more
BusinessWire
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
New analysis from the Phase 3 IMerge clinical trial, accepted as an oral presentation, explores relationship between treatment-emergent cytopenias and clinical response in LR-MDS Additional poster presentations
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.